Versatile Poly(d,l-lactide-co-glycolide), 75:25, Iv 0.2 Dl/g, Acid-terminated Family Size [mNOgrELU]

Poly(D,L-lactide-co-glycolide) 75:25, IV 0.2 dL/g, Acid-Terminated

Introducing our premium Poly(D,L-lactide-co-glycolide) 75:25, a highly versatile and reliable material designed for a wide range of applications. This acid-terminated variant offers exceptional chemical stability and biocompatibility, making it ideal for medical devices, drug delivery systems, and tissue engineering. With its intravenous (IV) concentration of 0.2 dL/g, this product ensures optimal performance and ease of use.

Product Properties and Specifications

Our Poly(D,L-lactide-co-glycolide) 75:25 is meticulously formulated to meet the highest industry standards. Key features include:

• High Purity: Ensuring reliable and consistent performance in various applications.
• Biocompatibility: Suitable for use in medical devices and drug delivery systems, minimizing the risk of adverse reactions.
• Biodegradability: Promotes the natural breakdown of the material over time, reducing environmental impact.

With an IV of 0.2 dL/g, this product offers excellent flow properties, making it ideal for injection-based applications. Its acid-terminated structure enhances the material's flexibility and processability, further expanding its potential uses.

Practical Uses and Benefits

Our Poly(D,L-lactide-co-glycolide) 75:25 is a versatile material that finds applications in various fields:

• Medical Devices: Used in the production of implants, stents, and drug delivery systems, offering a safe and effective solution for patients.
• Tissue Engineering: Facilitates the growth and regeneration of tissues, providing a promising approach for regenerative medicine.

Whether you are a researcher, engineer, or medical professional, this product is designed to meet your specific needs. Its exceptional properties and wide range of applications make it an indispensable tool in your arsenal. Choose our Poly(D,L-lactide-co-glycolide) 75:25 for quality, reliability, and innovation.